Tag: FDA-Approved Depression Treatment

Posted on

5 Critical Spravato Side Effects Every Patient Should Know Before Treatment

5 Critical Spravato Side Effects Every Patient Should Know Before Treatment

Published: February 24, 2025

Are you or a loved one considering Spravato for treatment-resistant depression? Understanding potential side effects before starting this breakthrough nasal spray therapy can dramatically improve your treatment experience and outcomes. At Spravato Treatment Centers of New Jersey, we believe informed patients achieve better results. This comprehensive guide reveals everything you need to know about managing Spravato side effects—information that could make the difference between treatment success and unnecessary discomfort.

What Exactly Is Spravato and How Does It Work?

Spravato (esketamine) works differently than traditional antidepressants by targeting the NMDA receptors in your brain. This FDA-approved medication offers hope for the 30% of depression patients who don’t respond to conventional treatments. Before discussing side effects, it’s important to understand that Spravato is always administered under medical supervision at certified treatment centers like ours in Chatham, New Jersey.

The 5 Most Common Spravato Side Effects You May Experience

Based on clinical studies and our extensive patient experience at Spravato Treatment Centers of New Jersey, these are the side effects most patients should be prepared for:

  1. Dissociation: Approximately 41% of patients experience feeling disconnected from reality or altered perceptions. This typically resolves within 1-2 hours after treatment.
  2. Dizziness and Nausea: Nearly 29% of patients report feeling dizzy or nauseated during or shortly after administration. Having a light meal before treatment can help minimize these effects.
  3. Blood Pressure Changes: About 17% of patients experience temporary increases in blood pressure, which is why monitoring is required during each treatment session.
  4. Sedation and Drowsiness: Around 23% of patients feel extremely relaxed or sleepy, which is why you’ll need someone to drive you home after treatment.
  5. Anxiety or Agitation: Some patients (13%) report temporary feelings of anxiety during the treatment experience.

Olivia’s Journey: From Treatment-Resistant Depression to Renewal

Olivia, a 45-year-old engineer from northern New Jersey, had battled treatment-resistant depression for over a decade. “I tried six different antidepressants and years of therapy with minimal improvement,” she recalls.

“I was skeptical about Spravato at first, especially after reading about the side effects online. But the team at Spravato Treatment Centers of New Jersey walked me through exactly what to expect. Yes, I experienced some dissociation during my first few treatments—it felt like I was floating outside myself—but the medical staff made me feel safe throughout the experience. By my third treatment, I noticed a significant improvement in my depression symptoms for the first time in years.”

Today, Olivia continues maintenance Spravato treatments and reports an 80% reduction in her depression symptoms. “The temporary side effects were a small price to pay for getting my life back,” she says.

How Our Medical Team Manages Side Effects

At Spravato Treatment Centers of New Jersey, our experienced medical team led by our Medical Director has developed protocols specifically designed to minimize discomfort during treatment:

  • Pre-treatment preparation guidance to reduce nausea
  • Comfortable, private treatment rooms with calming environments
  • Continuous monitoring by specialized healthcare professionals
  • Post-treatment recovery period with personalized support
  • Follow-up care to address any lingering side effects

Will Insurance Cover Spravato Despite Its Side Effects?

Many patients worry that insurance companies might deny coverage due to potential side effects. The good news is that most major insurance providers now recognize Spravato’s effectiveness for treatment-resistant depression. Visit our cost and insurance page to learn about coverage options and our assistance programs that make treatment accessible regardless of your financial situation.

Important Safety Information

Spravato carries a boxed warning for sedation, dissociation, and potential misuse. That’s why treatment can only be administered at certified facilities with proper monitoring. Our medical team conducts thorough evaluations to ensure Spravato is appropriate for each patient’s specific situation.

Frequently Asked Questions About Spravato Side Effects

Our patients often have specific concerns about side effects before starting treatment. Here are answers to the most common questions we receive at our Chatham clinic:

How long do the dissociative effects typically last?
Most patients find that dissociation resolves within 1-2 hours after treatment. By the time you’re cleared to go home (approximately 2 hours post-treatment), these effects have typically subsided significantly.

Can I drive after receiving Spravato?
No. Due to the potential for drowsiness and dissociation, you must arrange for someone to drive you home after each treatment session. You should not operate machinery or make important decisions until the following day.

Do side effects diminish with continued treatment?
Many patients report that side effects like dissociation and dizziness become less intense as they progress through their treatment course, though individual experiences vary.

Taking the Next Step in Your Treatment Journey

Understanding potential side effects is crucial when considering Spravato treatment, but it’s equally important to weigh these temporary discomforts against the potential for significant relief from treatment-resistant depression. At Spravato Treatment Centers of New Jersey, we’re committed to providing comprehensive support throughout your treatment journey.

Our experienced team has helped hundreds of patients like Olivia navigate Spravato therapy successfully, minimizing side effects while maximizing benefits. Ready to learn if Spravato might be right for you? Contact our Chatham office today to schedule a consultation and take the first step toward renewed mental wellness.

Author’s Bio

Dr. David Boguslavsky, MD, is a highly experienced family physician and medical acupuncturist with over two decades of clinical practice, who has emerged as a leader in mental health treatment, particularly in the field of depression. A graduate of Robert Wood Johnson Medical School, Dr. Boguslavsky is board-certified in both Family Medicine and Medical Acupuncture, showcasing his diverse medical expertise. His extensive experience spans a wide range of medical care, from acute illnesses to chronic condition management, with a particular focus on preventative care and pain treatment.

Notably, Dr. Boguslavsky has pioneered innovative approaches to depression treatment, having administered over 10,000 Spravato treatments, establishing himself as one of the foremost experts in this cutting-edge therapy. His unique blend of traditional Western medicine, Eastern acupuncture techniques, and advanced psychiatric treatments allows him to offer comprehensive, personalized care to his patients at PremierMD and Spravato Treatment Centers of NJ. Fluent in English and Russian, Dr. Boguslavsky brings a multifaceted approach to healthcare, combining the latest medical technologies with time-honored principles of doctor-patient relationships to address both physical and mental health needs.

Posted on

Breaking Free: 7 Ways Spravato is Revolutionizing Treatment-Resistant Depression Care

Breaking Free: 7 Ways Spravato is Revolutionizing Treatment-Resistant Depression Care

Are you or a loved one struggling with depression that seems unbeatable? You’re not alone. Treatment-resistant depression affects millions, but there’s a groundbreaking solution that’s changing lives: Spravato. In this article, we’ll explore how this innovative treatment is offering hope to those who thought they had run out of options.

Understanding Treatment-Resistant Depression

Treatment-resistant depression (TRD) is a complex condition where standard antidepressants fail to provide relief. It affects approximately 30% of those diagnosed with major depressive disorder, leaving many feeling hopeless and trapped in a cycle of despair.

Enter Spravato: A Game-Changer in Depression Treatment

Spravato, the brand name for esketamine, is a nasal spray that’s revolutionizing TRD treatment. Here are seven ways it’s making a difference:

  1. Rapid Relief: Unlike traditional antidepressants that can take weeks to work, Spravato can provide relief within hours or days.
  2. Novel Mechanism: It targets the glutamate system in the brain, offering a new approach for those who haven’t responded to conventional treatments.
  3. FDA-Approved: Spravato has been rigorously tested and approved by the FDA specifically for TRD.
  4. Supervised Administration: The treatment is given under medical supervision, ensuring safety and proper use.
  5. Complementary Therapy: It’s used in conjunction with oral antidepressants, potentially enhancing overall treatment efficacy.
  6. Long-Term Benefits: Many patients report sustained improvement in their symptoms over time.
  7. Hope for the Hopeless: For those who’ve tried everything else, Spravato offers a new chance at recovery.

Frequently Asked Questions About Spravato

Let’s address some common questions about this groundbreaking treatment:

1. How does Spravato work?

Spravato works by targeting the N-methyl-D-aspartate (NMDA) receptor in the brain, which is involved in mood regulation. This unique mechanism sets it apart from traditional antidepressants. For more detailed information on how Spravato works, visit our Spravato FAQ page.

2. What are the potential side effects?

While Spravato is generally well-tolerated, some patients may experience side effects such as dizziness, nausea, or dissociation. These effects are typically short-lived and manageable. For a comprehensive list of potential side effects, please refer to our Spravato Side Effects page.

3. Is Spravato covered by insurance?

Many insurance plans do cover Spravato treatment. At Spravato Treatment Centers of New Jersey, we work diligently to ensure our patients can access this life-changing treatment. For more information on costs and insurance coverage, visit our Spravato Cost and Insurance page.

A Story of Hope: Samuel’s Journey

Meet Samuel, a 71-year-old pastor who came to Spravato Treatment Centers of New Jersey in Hoboken with severe treatment-resistant depression. Despite years of various therapies and medications, Samuel had lost his zest for life and struggled to perform his pastoral duties.

“I felt like I was letting down my congregation and my family,” Samuel shared. “I had almost given up hope of ever feeling like myself again.”

After starting Spravato treatment, Samuel experienced a remarkable turnaround. Within weeks, he noticed a significant lift in his mood and energy levels. “It was as if a weight had been lifted from my shoulders,” he said. “I found myself eagerly planning sermons and connecting with my congregation in ways I hadn’t for years.”

Samuel’s story is just one of many success stories we’ve witnessed at our center. Our dedicated team, led by our experienced Medical Director, is committed to helping patients like Samuel reclaim their lives. To learn more about our expert staff, visit our About Us page.

The Future of Depression Treatment

Spravato represents a significant leap forward in the treatment of depression, especially for those who have not found relief through traditional methods. As research continues and more patients benefit from this innovative therapy, we’re seeing a paradigm shift in how we approach mental health care.

At Spravato Treatment Centers of New Jersey, we’re proud to be at the forefront of this revolution in depression treatment. Our team is dedicated to providing compassionate, expert care to help our patients overcome treatment-resistant depression and rediscover joy in their lives.

Conclusion: A New Chapter in Mental Health

Treatment-resistant depression doesn’t have to be the end of the story. With Spravato, many are writing new chapters filled with hope and healing. If you or someone you love is struggling with depression that hasn’t responded to other treatments, it may be time to explore Spravato as an option.

Remember, you’re not alone in this journey. Reach out to us at Spravato Treatment Centers of New Jersey to learn more about how we can help you or your loved one break free from the grip of treatment-resistant depression.

Author’s Bio

Dr. David Boguslavsky, MD, is a highly experienced family physician and medical acupuncturist with over two decades of clinical practice, who has emerged as a leader in mental health treatment, particularly in the field of depression. A graduate of Robert Wood Johnson Medical School, Dr. Boguslavsky is board-certified in both Family Medicine and Medical Acupuncture, showcasing his diverse medical expertise. His extensive experience spans a wide range of medical care, from acute illnesses to chronic condition management, with a particular focus on preventative care and pain treatment. Notably, Dr. Boguslavsky has pioneered innovative approaches to depression treatment, having administered over 10,000 Spravato treatments, establishing himself as one of the foremost experts in this cutting-edge therapy. His unique blend of traditional Western medicine, Eastern acupuncture techniques, and advanced psychiatric treatments allows him to offer comprehensive, personalized care to his patients at PremierMD and Spravato Treatment Centers of NJ. Fluent in English and Russian, Dr. Boguslavsky brings a multifaceted approach to healthcare, combining the latest medical technologies with time-honored principles of doctor-patient relationships to address both physical and mental health needs.
Posted on

Spravato and Suicide Prevention: Understanding the Potential Benefits

 

Spravato: A Breakthrough in Suicide Prevention?
Key Insights You Need to Know

 

 

Introduction

Spravato has emerged as a new contender in the ongoing battle against depression and suicide. This groundbreaking treatment has sparked hope and curiosity among mental health professionals and patients alike. But what exactly is Spravato, and how does it fit into the landscape of suicide prevention? In this article, we’ll explore the potential benefits of Spravato and its role in addressing one of the most pressing mental health challenges of our time.

Understanding Spravato: The Basics

Spravato, also known by its generic name esketamine, is a nasal spray derived from ketamine. Approved by the FDA in 2019, it’s designed to treat treatment-resistant depression and reduce suicidal thoughts. Unlike traditional antidepressants that can take weeks to show effects, Spravato works rapidly, often providing relief within hours or days.

7 Key Insights About Spravato and Suicide Prevention

  1. Rapid Action in Crisis Situations

    One of Spravato’s most promising features is its quick onset of action. For individuals experiencing acute suicidal ideation, this rapid response can be lifesaving. Traditional antidepressants often take 4-6 weeks to show significant effects, leaving patients vulnerable during this critical period. Spravato’s ability to reduce depressive symptoms within hours could provide a crucial buffer, giving patients and healthcare providers valuable time to implement comprehensive treatment plans.

  2. Effectiveness in Treatment-Resistant Depression

    Many individuals who consider suicide have struggled with treatment-resistant depression, meaning they’ve tried multiple antidepressants without success. Spravato offers hope for this population, with studies showing significant improvement in depressive symptoms among patients who didn’t respond to other treatments. By addressing this notoriously difficult-to-treat form of depression, Spravato could play a vital role in reducing suicide risk among a particularly vulnerable group.

  3. Neuroplasticity and Long-Term Benefits

    Research suggests that Spravato may promote neuroplasticity – the brain’s ability to form new neural connections. This could have long-lasting effects beyond immediate symptom relief. By potentially “rewiring” the brain, Spravato might help patients develop more resilient thought patterns and coping mechanisms, contributing to long-term suicide prevention.

  4. Supervised Administration for Safety

    Unlike many psychiatric medications, Spravato is administered under direct medical supervision. This approach ensures patient safety and allows for immediate intervention if needed. For individuals at high risk of suicide, this controlled environment provides an additional layer of protection and support during treatment.

  5. Combination with Comprehensive Care

    Spravato is not a standalone solution but part of a comprehensive treatment approach. It’s typically used in conjunction with oral antidepressants and psychotherapy. This multi-faceted strategy addresses the complex nature of suicidal ideation, targeting both immediate symptoms and underlying issues.

  6. Potential for Reducing Hospitalization Rates

    Early studies suggest that Spravato might reduce the need for hospitalization in patients with severe depression and suicidal thoughts. By providing rapid depression symptom relief, it could potentially allow more patients to be treated safely on an outpatient basis, reducing the strain on hospital resources and minimizing disruption to patients’ lives.

  7. Ongoing Research and Future Potential

    While initial results are promising, research on Spravato’s long-term effects and its role in suicide prevention is ongoing. As more data becomes available, we may uncover additional benefits or refine treatment protocols to maximize its effectiveness in preventing suicide.

Frequently Asked Spravato Questions

Is Spravato addictive?

While Spravato is related to a medication with a potential for abuse, the controlled administration and monitoring of Spravato significantly reduce this risk. However, patients are closely monitored for any signs of dependence.

Who is eligible for Spravato treatment?

Spravato is typically prescribed for adults with treatment-resistant depression or major depressive disorder with acute suicidal ideation. Eligibility is determined by a healthcare provider based on individual medical history and previous treatment responses.

What are the side effects of Spravato?

Common side effects include dizziness, nausea, and dissociation. These effects are typically short-lived and monitored during the supervised administration period.

How long does Spravato treatment last?

Treatment plans vary, but typically involve twice-weekly treatments for the first month, followed by once-weekly or once every two weeks, depending on individual response and needs.

Conclusion: A Promising Tool in Suicide Prevention

Spravato represents a significant advancement in the treatment of severe depression and suicidal ideation. Its rapid action, effectiveness in treatment-resistant cases, and potential for long-term brain changes offer new hope in the critical field of suicide prevention. While it’s not a panacea, Spravato adds a powerful tool to the arsenal of mental health professionals working to save lives.

As research continues and clinical experience grows, we may see Spravato playing an increasingly important role in comprehensive suicide prevention strategies. For now, it stands as a testament to the ongoing progress in mental health treatment and a beacon of hope for those struggling with the darkest depths of depression.

If you or someone you know is experiencing suicidal thoughts, it’s crucial to seek professional help immediately. While Spravato offers new possibilities, it’s just one part of a broader approach to mental health and suicide prevention. Remember, help is always available, and with proper treatment and support, recovery is possible.

 

 

Author’s Bio

Dr. David Boguslavsky, MD, is a highly experienced family physician and medical acupuncturist with over two decades of clinical practice, who has emerged as a leader in mental health treatment, particularly in the field of depression. A graduate of Robert Wood Johnson Medical School, Dr. Boguslavsky is board-certified in both Family Medicine and Medical Acupuncture, showcasing his diverse medical expertise. His extensive experience spans a wide range of medical care, from acute illnesses to chronic condition management, with a particular focus on preventative care and pain treatment.

Notably, Dr. Boguslavsky has pioneered innovative approaches to depression treatment, having administered over 10,000 Spravato treatments, establishing himself as one of the foremost experts in this cutting-edge therapy. His unique blend of traditional Western medicine, Eastern acupuncture techniques, and advanced psychiatric treatments allows him to offer comprehensive, personalized care to his patients at PremierMD and Spravato Treatment Centers of NJ. Fluent in English and Russian, Dr. Boguslavsky brings a multifaceted approach to healthcare, combining the latest medical technologies with time-honored principles of doctor-patient relationships to address both physical and mental health needs.